Advances and challenges in the treatment of esophageal cancer
Esophageal cancer (EC) is one of the most common cancers with high morbidity and mortality rates. EC includes two histological subtypes, namely esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). ESCC primarily occurs in East Asia, whereas EAC occurs in Western countries....
Saved in:
Main Authors: | Shiming He (Author), Jian Xu (Author), Xiujun Liu (Author), Yongsu Zhen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A recombinant scFv antibody-based fusion protein that targets EGFR associated with IMPDH2 downregulation and its drug conjugate show therapeutic efficacy against esophageal cancer
by: Shiming He, et al.
Published: (2022) -
PD-1 Inhibitors in the Advanced Esophageal Cancer
by: Ye Hong, et al.
Published: (2019) -
Cost-Effectiveness Analysis of Pembrolizumab in Patients With Advanced Esophageal Cancer Based on the KEYNOTE-181 Study
by: Mei Zhan, et al.
Published: (2022) -
Esophageal Cancer in Kazakhstan: Multi-omic Research Challenges
by: Saule Rakhimova, et al.
Published: (2014) -
MULTIMODAL APPROACH TO THE TREATMENT OF ESOPHAGEAL CANCER
by: U.B. URMONOV, et al.
Published: (2019)